about
Quantitation of human seroresponsiveness to Merkel cell polyomavirusCellular and viral factors regulating Merkel cell polyomavirus replicationRisk factors for adverse outcome in persons with pneumococcal pneumonia.Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulatorMerkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomasT antigen mutations are a human tumor-specific signature for Merkel cell polyomavirusHuman Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassaysClonal integration of a polyomavirus in human Merkel cell carcinomaHuman transcriptome subtraction by using short sequence tags to search for tumor viruses in conjunctival carcinomaThe conundrum of causality in tumor virology: the cases of KSHV and MCVTwenty years of KSHVAsymmetric Assembly of Merkel Cell Polyomavirus Large T-Antigen Origin Binding Domains at the Viral OriginKSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcomaDetection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infectionKaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomasMolecular virology of Kaposi's sarcoma-associated herpesvirusComplex alternative cytoplasmic protein isoforms of the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 generated through noncanonical translation initiation.Intrabodies targeting the Kaposi sarcoma-associated herpesvirus latency antigen inhibit viral persistence in lymphoma cells.Transcriptional analysis of latent and inducible Kaposi's sarcoma-associated herpesvirus transcripts in the K4 to K7 region.A sensitive non-radioactive northern blot method to detect small RNAsKaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens.Coupled transcriptome and proteome analysis of human lymphotropic tumor viruses: insights on the detection and discovery of viral genes.Group A meningococcal carriage in travelers returning from Saudi Arabia.Survivin is a therapeutic target in Merkel cell carcinoma.Seroprevalence of Kaposi's sarcoma-associated herpesvirus in various populations in Cuba.Multicolor microRNA FISH effectively differentiates tumor typesMerkel cell polyomavirus small T antigen controls viral replication and oncoprotein expression by targeting the cellular ubiquitin ligase SCFFbw7.Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma.Human DNA tumor viruses generate alternative reading frame proteins through repeat sequence recoding.Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV.Human polyomavirus 7-associated pruritic rash and viremia in transplant recipients.Large T and small T antigens of Merkel cell polyomavirus.Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985.Survey for human polyomaviruses in cancer.Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.Merkel cell polyomavirus large T antigen disrupts lysosome clustering by translocating human Vam6p from the cytoplasm to the nucleus.Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors.Response of Merkel cell polyomavirus-positive merkel cell carcinoma xenografts to a survivin inhibitor.Use of a multiantigen detection algorithm for diagnosis of Kaposi's sarcoma-associated herpesvirus infection.
P50
Q21559417-935F7A95-E510-4B74-9635-BA32D8535C80Q21560943-92F4318E-F437-41DE-A89B-A4A0AC1C1296Q23910031-2A5470DB-9A31-40A0-BCBA-80BCBDAED548Q24609227-0444D6C7-A779-4121-8CA7-37967E5EADF7Q24619452-F2ECA060-0217-4C13-96AA-E4CD4E475581Q24645091-464FEF23-9591-490D-A3DA-04A6B21233FDQ24650632-2D0F6D82-C1B2-449B-85DE-458560FF6D63Q24657675-98AB5EE6-5B50-41A9-94F7-5ABA3BFCD778Q24671700-C841DBB0-4EAD-44E2-9A01-AC0EB11B012DQ26863112-09058479-4B0F-4EDC-9605-9B2D754E8800Q26999889-D03D71DC-89CC-4FCC-9AAD-72A8E8103604Q27667545-C8692A6E-3391-48E7-803D-D9C10232213FQ28284765-A37523FE-EC2D-4F49-8171-84473718B1F4Q28299060-381C5233-6BC7-4953-817B-ED7EFDABE561Q28299069-FAE909A6-C14A-4450-A2FC-66D1A5FEE809Q28363323-43336DB6-488A-4498-9D40-04451093FEA2Q30535717-2FD9A8C4-27A8-4827-A883-95DE58A47225Q33221441-355CBACF-A7C5-4CD0-BA53-B385A8F66C16Q33227754-2ADE3F83-75E9-40E4-B714-B9984F682D9AQ33783230-621EA560-9B65-49B3-B95B-057D74F68459Q33834993-47ADCE2F-A7F1-44A8-B620-E0D300974AFCQ33966574-A0A09DFE-676D-462A-B92F-CBB203B98027Q34106764-0DE7D7F1-4E72-4CAA-9775-C449F0457BA9Q34169038-8E79D9B8-CEA4-4F88-91B1-B3303F0EEBA2Q34273814-0B112DF5-ADAB-4217-A79D-9F997FC82BE5Q34330692-4B44E1D3-3168-432C-9102-CD0E72A0B3E2Q34348056-5D35F7CF-4E8C-4075-B06D-E528AD2C523FQ34364753-50CF817C-5E80-4D04-9C7C-16A4474504BAQ34383343-1B8FBC6F-C846-457A-B0C6-2E548ED6EE57Q34383861-544C8ED0-5C87-4751-8D32-0BE77B9A6179Q34408877-4AEA82D7-237C-4953-AE50-573228557852Q34439232-5F765939-DA84-4916-ACC6-06BFFAF30027Q34462768-B849D801-3A53-40A0-845C-B0F96F6F3493Q34477586-4BB77667-E2F8-4E52-A5F1-B2FB6D6954B7Q34520540-EB083521-48AD-4A90-8CC4-2DE268E1C853Q34735858-A47BABA7-3A97-42D6-AF22-47C0F9F9EAB5Q34947967-FBFF8A6F-6A02-4105-A659-3D4D0D4801FFQ34985137-3085C330-EB1C-41D2-8992-A5CFFF9AC7BAQ35049080-719D9105-1D49-47FF-B74C-D97C7D3D24DFQ35073499-910F9B37-1AC7-4AB0-96BF-8A9E2DFF4773
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Patrick Moore
@fr
Patrick S Moore
@en
Patrick S Moore
@es
Patrick S Moore
@nl
Patrick S Moore
@sl
type
label
Patrick Moore
@fr
Patrick S Moore
@en
Patrick S Moore
@es
Patrick S Moore
@nl
Patrick S Moore
@sl
prefLabel
Patrick Moore
@fr
Patrick S Moore
@en
Patrick S Moore
@es
Patrick S Moore
@nl
Patrick S Moore
@sl
P1053
F-3960-2011
P106
P21
P31
P3829
P496
0000-0002-8132-858X